Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model

INTRODUCTION: There is increasing scientific evidence to substantiate using low‐dose glucagon as a supplement to insulin therapy in artificial pancreata for diabetes mellitus type 1. The delivery of both these hormones intraperitoneally would mimic normal physiology. However, our knowledge of the ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Teigen, Ingrid Anna, Åm, Marte Kierulf, Carlsen, Sven Magnus, Christiansen, Sverre Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321685/
https://www.ncbi.nlm.nih.gov/pubmed/35416407
http://dx.doi.org/10.1111/bcpt.13731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321685/
https://www.ncbi.nlm.nih.gov/pubmed/35416407
http://dx.doi.org/10.1111/bcpt.13731

Ejemplares similares